Reply to correspondence on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
Reply to: Correspondence on Editorial regarding âGenetically modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical settingâ
Authors
- Antonio Bertoletti (ORCID: https://orcid.org/0000-0002-2942-0485)
- Anthony T. Tan (ORCID: https://orcid.org/0000-0003-0079-8203)
Institutions
- Duke-NUS Medical School (SG)
Publication Details
- Journal
- Clinical and Molecular Hepatology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.3350/cmh.2024.0867
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00